RA Capital Management - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 130 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$51,318,000
-9.7%
5,290,4810.0%0.82%
-3.9%
Q1 2021$56,820,000
-27.0%
5,290,4810.0%0.86%
-21.2%
Q4 2020$77,823,000
-11.1%
5,290,481
-14.2%
1.09%
-32.1%
Q3 2020$87,572,000
+75.6%
6,162,6940.0%1.60%
+64.8%
Q2 2020$49,856,000
+94.0%
6,162,694
-3.1%
0.97%
+19.7%
Q1 2020$25,700,0006,361,4460.81%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Anson Funds Management LP 174,174$298,0000.17%
Matrix Capital Management Company, LP 2,288,560$3,913,0000.13%
Samsara BioCapital, LLC 71,619$122,0000.12%
NEA Management Company, LLC 1,250,000$2,138,0000.08%
Tekla Capital Management LLC 446,099$763,0000.03%
PLATINUM INVESTMENT MANAGEMENT LTD 175,339$306,0000.01%
Artal Group S.A. 150,000$257,0000.01%
Baker Brothers Advisors 505,262$864,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$34,0000.01%
OXFORD ASSET MANAGEMENT LLP 57,055$98,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders